PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) Sees Significant Decrease in Short Interest

PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) saw a large decrease in short interest in the month of August. As of August 31st, there was short interest totaling 17,878 shares, a decrease of 81.4% from the August 15th total of 95,953 shares. Based on an average trading volume of 345,630 shares, the short-interest ratio is presently 0.1 days.

PharmaTher Price Performance

OTCMKTS:PHRRF traded down $0.00 during midday trading on Friday, hitting $0.04. 11,620 shares of the stock were exchanged, compared to its average volume of 165,396. PharmaTher has a one year low of $0.03 and a one year high of $0.30. The business has a 50-day moving average price of $0.04 and a two-hundred day moving average price of $0.05.

About PharmaTher

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain and Rett syndrome, and anesthesia and procedural sedation, as well as Ischemia reperfusion injury. It also develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures.